Next Generation Sequencing (NGS) Market by Application, Technology, Work-flow and End User - Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 192 Pages

Description

Industry Trend Analysis

In 2014, the global next-generation sequencing market was evaluated around USD 2.82 billion and is expected to reach approximately USD 15.04 billion by 2023 while registering itself at a compound annual growth rate (CAGR) of 20.43% over the forecast period. Expansion of more rapid and efficient genomic sequencing methodologies is projected to fuel the NGS platforms adoption further and consequently regulating industrial expansion. Rising automation within the pre-sequencing protocols is projected to boost progress in the global industry in the approaching years. Use of innovative platforms for the growth of custom-made medicine by clinical analysis at a genetic stage is a major factor that is likely to improve NGS demand during the forecast years. An escalating amount of R&D projects in the areas of transcriptomics, metabolomics, and proteomics are anticipated to fuel the technology demand as well. Genomics and proteomics function with and on a massive array of structural data that demands to be accumulated and classified through subsequent integrated data analysis and sequence determination. The introduction of novel services and products by well-known market giants is anticipated to boost the growth during the forecast years. Additionally, growing inclination of drug developers and scientists for the NGS technology in an attempt to employ the avenues of tailored medicine has established to be a high rise for demanding these platforms with the aim of gaining penetrations into the genetic enterprises of a huge amount of organisms. This augments in demand is expected to boost the NGS industry over the forecast period.

Application Outlook and Trend Analysis

Application-wise NGS technology has profitable approaches in preimplantation and prenatal genetic screening, developmental oncology, HLA typing/immune system monitoring, epidemiology & drug development, metagenomics, agrigenomics & forensics, clinical investigation, and consumer genomics. Oncology is expected to demonstrate profitable growth in the approaching years owing to the speedily developing of sequencing capabilities that facilitate directed sequence determination of an amount of cancer genes that allow oncologists to acquire genetic data exist in few of the less available dense gene clusters concerning cancer tumors and cells.

Technology Outlook and Trend Analysis

Targeted sequencing reported for the leading share due to the existence of numerous benefits linked with a minor dataset and decline in sequencing prices. Moreover, expansion in the amount of protein expression analysis projects is projected to rise due to the existence of DNA-based sequence data sets. Whole genome sequencing (WGS) includes de novo genome, microbial, and genome applications. It is anticipated to observe top year on year growth due to an amplified amount of research programs focused at mapping non-human and human whole genomes joint with decreasing WGS costs.

Work flow Outlook and Trend Analysis

In 2015, sequencing ruled in terms of market revenue share and is anticipated to maintain its supremacy over the projected period. Subsequent to this step, data analysis is projected to experience major growth than rest steps of workflow due to the existence of extensive activities for development and upgradation of novel algorithms in an attempt to render rapid outcome following data analysis.

End User Outlook and Trend Analysis

Usage of these solutions in R&D projects that are executed in the research centers and universities are prenominal for the leading share due to the existence of a huge amount of R&D projects. On-site bioinformatics courses provision which includes the workshops on the actual implementation of data analysis and NGS are also anticipated to fuel revenue produced via academic research in the approaching years. Rising NGS-based smaller scale platforms’ adoption for medical diagnostics is also a major end market projected to fuel demand during the future.

Regional Outlook and Trend Analysis

In 2015, North American regional NGS market reported for the leading share. This huge share can be reported for the existence of an improved technological medical framework, rising adoption of declining in the price of sequencing for each base pair, and elevated R&D funding for proteomic and genomic sequence determination for research of biomarkers. Also, most of the respondents for clinical & academic use are situated in the UK, U.S., and Germany due to the existence of numerous universities that present courses for molecular biology in the region thus affecting the expansion of NGS industry in European and North American regional market. Asia Pacific region is anticipated to grow at the leading rate with a compound annual growth rate of around 18% over the forecast years due to escalating investment for escalating healthcare awareness levels of the regional population, development of healthcare, and escalating residual and per capita income levels.

Competitive Outlook and Trend Analysis

The major market players in global next-generation sequencing market are Beijing Genomics Institute, Pacific Biosciences, Knome Inc., F Hoffmann-La Roche, Thermo Fisher Scientific, GATC Biotech AG., Oxford Nanopore Technologies Inc., Biomatters Ltd., Agilent Technologies Inc., DNAStar Inc., Helicos BioSciences, CLC Bio (Qiagen), Macrogen Inc., and Illumina Inc. The rivalry between market players seeking to achieve a grip in the rapidly-developing biotech segment is engaging on numerous battlefields. Companies are concentrating on the advent of economical sequencing devices in regular healthcare checkups.

The global next generation sequencing market is segmented as follows –

By Application


Oncology



Clinical Investigation


Idiopathic Diseases
Inherited Diseases
Infectious Diseases
Non-Communicable / Other Diseases





Reproductive Health


NIPT
PGT
Newborn/Genetic Screening





HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics


By Technology


Targeted Sequencing Analysis



DNA Based Targeted Sequencing Analysis
RNA Based Targeted Sequencing Analysis



Whole Genome Sequencing
Whole Exome Sequencing


By Work flow


Pre-sequencing



NGS Library Preparation Kits
NGS Semi-Automated Library Preparation
NGS Automated Library Preparation
Clonal Amplification



Sequencing



Data Analysis



Primary Data Analysis
Secondary Data Analysis
Tertiary Data Analysis


By End User


Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users


By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:

· What was the market size in 2014 and forecast from 2015 to 2023`

· What will be the industry market growth from 2015 to 2023`

· What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`

· What are the major segments leading the market growth and why`

· Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growth of companion diagnostics and personalized medicine
3.2.1.2. Expansion of technological advancements in cloud computing and data integration
3.2.1.3. Increasing clinical prospect for NGS technology
3.2.2. Restraints
3.2.2.1. Lack of computational efficiency for data management
3.2.3. Opportunities
3.2.3.1. Technological advancement in cancer diagnostic process
4. Next Generation Sequencing (NGS) Market, By Application
4.1. Introduction
4.2. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Application (2014-2017)
4.2.1. Global Next Generation Sequencing (NGS) Sales and Sales Share By Application (2014-2017)
4.2.2. Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Application (2014-2017)
4.3. Next Generation Sequencing (NGS) Market Assessment and Forecast, By Application, 2014-2023
4.4. Oncology
4.4.1.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5. Clinical Investigation
4.5.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
4.5.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.3. Idiopathic Diseases
4.5.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.4. Inherited Diseases
4.5.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.5. Infectious Diseases
4.5.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.6. Non-Communicable / Other Diseases
4.5.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6. Reproductive Health
4.6.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
4.6.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.3. NIPT
4.6.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.4. PGT
4.6.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.5. Newborn/Genetic Screening
4.6.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.7. HLA Typing/Immune System Monitoring
4.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.8. Metagenomics, Epidemiology & Drug Development
4.8.1. arket Assessment and Forecast, By Region, 2014-2023 ($Million)
4.9. Agrigenomics & Forensics
4.9.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.10. Consumer Genomics
4.10.1.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5. Next Generation Sequencing (NGS) Market, By Technology
5.1. Introduction
5.2. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Technology (2014-2017)
5.2.1. Global Next Generation Sequencing (NGS) Sales and Sales Share By Technology (2014-2017)
5.2.2. Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Technology (2014-2017)
5.3. Next Generation Sequencing (NGS) Market Assessment and Forecast, By Technology, 2014-2023
5.4. Targeted Sequencing Analysis
5.4.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
5.4.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.4.3. DNA Based Targeted Sequencing Analysis
5.4.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.4.4. RNA Based Targeted Sequencing Analysis
5.4.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.5. Whole Genome Sequencing
5.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.6. Whole Exome Sequencing
5.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6. Next Generation Sequencing (NGS) Market, By Work-flow
6.1. Introduction
6.2. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Work-flow (2014-2017)
6.2.1. Global Next Generation Sequencing (NGS) Sales and Sales Share By Work-flow (2014-2017)
6.2.2. Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Work-flow (2014-2017)
6.3. Next Generation Sequencing (NGS) Market Assessment and Forecast, By Work-flow, 2014-2023
6.4. Pre-sequencing
6.4.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
6.4.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.4.3. NGS Library Preparation Kits
6.4.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.4.4. NGS Semi-Automated Library Preparation
6.4.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.4.5. NGS Automated Library Preparation
6.4.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.4.6. Clonal Amplification
6.4.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5. Sequencing
6.5.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
6.5.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5.3. Data Analysis
6.5.3.1. Market Assessment and Forecast, By Type, 2014-2023 ($Million)
6.5.3.2. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5.3.3. Primary Data Analysis
6.5.3.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5.3.4. Secondary Data Analysis
6.5.3.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5.3.5. Tertiary Data Analysis
6.5.3.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7. Next Generation Sequencing (NGS) Market, By End User
7.1. Introduction
7.2. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By End User (2014-2017)
7.2.1. Global Next Generation Sequencing (NGS) Sales and Sales Share By End User (2014-2017)
7.2.2. Global Next Generation Sequencing (NGS) Revenue and Revenue Share By End User (2014-2017)
7.3. Next Generation Sequencing (NGS) Market Assessment and Forecast, By End User, 2014-2023
7.4. Academic Research
7.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.5. Clinical Research
7.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.6. Hospitals & Clinics
7.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.7. Pharma & Biotech Entities
7.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.8. Other Users
7.8.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
8. Next Generation Sequencing (NGS) Market, By Region
8.1. Introduction
8.2. Next Generation Sequencing (NGS) Market Assessment and Forecast, By Region, 2014-2023 ($Million)
8.3. Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Regions
8.3.1. Global Next Generation Sequencing (NGS) Sales by Regions (2014-2017)
8.3.2. Global Next Generation Sequencing (NGS) Revenue by Regions (2014-2017)
8.4. North America
8.4.1. North America Next Generation Sequencing (NGS) Sales and Growth Rate (2014-2017)
8.4.2. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.4.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.4. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.4.5. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.6.1. U.S.
8.4.6.1.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.1.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.4.6.1.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.6.2. Canada
8.4.6.2.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.2.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.4.6.2.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.6.3. Mexico
8.4.6.3.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.3.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.4.6.3.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.4.6.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5. Europe
8.5.1. Europe Next Generation Sequencing (NGS) Sales and Growth Rate (2014-2017)
8.5.2. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.5.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.4. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.5. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.1. Germany
8.5.6.1.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.1.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.1.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.2. France
8.5.6.2.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.2.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.2.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.3. UK
8.5.6.3.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.3.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.3.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.4. Italy
8.5.6.4.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.4.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.4.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.5. Spain
8.5.6.5.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.5.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.5.3. Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.6. Russia
8.5.6.6.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.6.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.6.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.6.7. Rest of Europe
8.5.6.7.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.7.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.5.6.7.3. Assessment and Forecast, By Application, 2014-2023 ($Million)
8.5.6.7.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6. Asia-Pacific
8.6.1. Asia-Pacific Next Generation Sequencing (NGS) Sales and Growth Rate (2014-2017)
8.6.2. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.6.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.4. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.5. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.1. Japan
8.6.6.1.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.1.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.1.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.2. China
8.6.6.2.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.2.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.2.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.3. Australia
8.6.6.3.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.3.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.3.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.4. India
8.6.6.4.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.4.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.4.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.5. South Korea
8.6.6.5.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.5.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.5.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.6. Taiwan
8.6.6.6.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.6.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.6.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.6.7. Rest of Asia-Pacific
8.6.6.7.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.7.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.6.6.7.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.6.6.7.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7. Rest of the World
8.7.1. Rest of the World Next Generation Sequencing (NGS) Sales and Growth Rate (2014-2017)
8.7.2. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.7.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.4. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.5. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.1. Brazil
8.7.6.1.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.1.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.1.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.2. Turkey
8.7.6.2.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.2.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.2.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.3. Saudi Arabia
8.7.6.3.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.3.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.3.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.4. South Africa
8.7.6.4.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.4.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.4.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.5. United Arab Emirates
8.7.6.5.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.5.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.5.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.7.6.6. Others
8.7.6.6.1. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.6.2. Market Assessment and Forecast, By Technology, 2014-2023 ($Million)
8.7.6.6.3. Market Assessment and Forecast, By Application, 2014-2023 ($Million)
8.7.6.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
9. Company Profiles
9.1. Roche Holding AG
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.2. Agilent Technologies
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.3. Genomatix Software Gmbh
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.4. Illumina, Inc.
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.5. Dnastar, Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.6. Oxford Nanopore Technologies, Ltd.
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.7. Qiagen N.V.
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.8. Genomatix Software Gmbh
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.9. Knome, Inc.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.10. Macrogen, Inc.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
9.11. Thermo Fisher Scientific Inc.
9.11.1. Business Overview
9.11.2. Product Portfolio
9.11.3. Strategic Developments
9.11.4. Next Generation Sequencing (NGS) Sales, Revenue and Market Share
10. Global Next Generation Sequencing (NGS) Market Competition, by Manufacturer
10.1. Global Next Generation Sequencing (NGS) Sales and Market Share by Manufacturer (2016-2017)
10.2. Global Next Generation Sequencing (NGS) Revenue and Market Share by Manufacturer (2016-2017)
10.3. Top 5 Next Generation Sequencing (NGS) Manufacturer Market Share
10.4. Market Competition Trend


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Next Generation Sequencing (NGS) Market.

Request Sample

* mark fields are compulsory